| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |